Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

Jars of sweets, with red, heart-shaped candies in the foreground

High levels of glucose in the blood ‘reprogrammes’ stem cells, leading to a lasting increase in the risk of developing dangerous atherosclerosis, according to research led by Professor Robin Choudhury

Radcliffe Department of Medicine researchers found that high blood glucose, a hallmark of diabetes, alters stem cells in the bone marrow that go on to become white blood cells called macrophages. As a result, these macrophages become inflammatory and contribute to the development of atherosclerotic plaques that can cause heart attacks.

This finding explains why people with diabetes are at increased risk of heart attack, even after their blood glucose levels are brought back under control, a paradox that has troubled doctors for years.

Nearly five million people in the UK have diabetes1, and adults with the condition have double the risk of having a heart attack.2. These findings open new possibilities for treatments that could reduce the risk of heart and circulatory disease in people with diabetes.

The team investigated the differences in white blood cells in people with and without type 2 diabetes. They removed the white blood cells from blood samples and grew them in an environment with normal glucose levels. Those from people with type 2 diabetes showed a greatly exaggerated inflammatory response compared to the cells from people without the condition.

Researchers also extracted stem cells from the bone marrow of mice with and without diabetes and transplanted these into mice with normal blood glucose levels. The bone marrow taken from diabetic mice ‘remembered’ its exposure to high levels of glucose and as a result the mice receiving this bone marrow developed almost double the amount of atherosclerotic plaques.

When the team looked at the mouse macrophages in more detail they found that those that had developed from stem cells in the bone marrow of diabetic mice had been permanently altered to become more inflammatory.

The team now want to explore new avenues for treatments based on this finding. They also want to find out whether short periods of increased blood glucose in people without diabetes have this damaging effect.

Professor Robin Choudhury, Professor of Cardiovascular Medicine at the Radcliffe Department of Medicine, University of Oxford, led the research. He said “Our study is the first to show that diabetes causes long-term changes to the immune system, and how this might account for the sustained increase in the risk of heart attack.

We need to change the way we think about, and treat, diabetes. By focussing too narrowly on a managing a person’s blood sugar levels we’re only addressing part of the problem.
- Professor Robin Choudhury

“Right now, people with diabetes aren’t receiving effective treatment for their increased risk of heart and circulatory disease. These findings identify new opportunities for preventing and treating the complications of diabetes.”
Professor Sir Nilesh Samani, Medical Director at the British Heart Foundation, which funded the research, said:
“While treatments for diabetes have improved, people with diabetes still have a higher risk of heart attacks. This research may provide part of the explanation for why this is the case and potentially pave the way for new treatments to reduce the risk of heart attack for the millions of people living with diabetes.”

This research was also funded by the Tripartite Immunometabolism Consortium (TrIC) – Novo Nordisk Foundation.

Read the full paper

Text courtesy of BHF. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

11 RDM researchers awarded Associate Professorships

We are delighted to announce that 11 RDM researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Medical Sciences Division.